Monopar Therapeutics Inc (MNPR)
0.7272
+0.07
(+10.18%)
USD |
NASDAQ |
May 03, 16:00
0.7272
0.00 (0.00%)
After-Hours: 20:00
Monopar Therapeutics Free Cash Flow: -7.858M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -7.858M |
September 30, 2023 | -7.614M |
June 30, 2023 | -7.823M |
March 31, 2023 | -7.032M |
December 31, 2022 | -7.229M |
September 30, 2022 | -7.959M |
June 30, 2022 | -7.752M |
March 31, 2022 | -7.847M |
December 31, 2021 | -7.317M |
September 30, 2021 | -6.526M |
June 30, 2021 | -5.885M |
March 31, 2021 | -5.475M |
December 31, 2020 | -4.662M |
Date | Value |
---|---|
September 30, 2020 | -4.090M |
June 30, 2020 | -3.403M |
March 31, 2020 | -3.147M |
December 31, 2019 | -3.018M |
September 30, 2019 | -2.868M |
June 30, 2019 | -2.854M |
March 31, 2019 | -2.868M |
December 31, 2018 | -2.680M |
September 30, 2018 | -2.977M |
June 30, 2018 | -3.573M |
March 31, 2018 | -3.125M |
December 31, 2017 | -2.628M |
Free Cash Flow Range, Past 5 Years
-7.959M
Minimum
Sep 2022
-2.854M
Maximum
Jun 2019
-5.808M
Average
-6.526M
Median
Sep 2021
Free Cash Flow Benchmarks
Motus GI Holdings Inc | -11.30M |
SeaStar Medical Holding Corp | -10.28M |
Perspective Therapeutics Inc | -37.98M |
Electromed Inc | 3.653M |
Xtant Medical Holdings Inc | -10.97M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -1.546M |
Cash from Investing (Quarterly) | 2.970M |
Cash from Financing (Quarterly) | 0.3345M |
Free Cash Flow Per Share (Quarterly) | -0.1056 |
Free Cash Flow Yield | -78.19% |